-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Interpace Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Interpace Biosciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $1.91M.
- Interpace Biosciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was $6.35M, a 311% increase year-over-year.
- Interpace Biosciences, Inc. annual Operating Income (Loss) for 2023 was $2.8M.
- Interpace Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$3.62M, a 42.9% increase from 2021.
- Interpace Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$6.34M, a 75.7% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)